clinical trial · NCT00649675
Food Study of Meloxicam Tablets 15 mg and Mobic® Tablets 15 mg
HealthyMeloxicam Tablets 15 mgMobic® Tablets 15 mg
brief summary
The objective of this study was to investigate the bioequivalence of Mylan's meloxicam 15 mg tablets and Boehringer Ingelheim's Mobic® 15 mg tablets following a single, oral 15 mg (1 x 15 mg) dose administration under fed conditions.
started
Aug 1, 2004
primary completion
Sep 1, 2004
completion
Sep 1, 2004
last updated
Apr 24, 2024
official title
Single-Dose Food In Vivo Bioequivalence Study of Meloxicam Tablets (15 mg; Mylan) and Mobic® Tablets (15 mg; Boehringer Ingelheim) in Healthy Volunteers
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol